Targeting the Adipose Tissue in COVID-19 - PubMed (original) (raw)

Comment

. 2020 Jul;28(7):1178-1179.

doi: 10.1002/oby.22844. Epub 2020 May 21.

Affiliations

• PMID: 32314871
• PMCID: PMC7264780
• DOI: 10.1002/oby.22844

Comment

Targeting the Adipose Tissue in COVID-19

Alexis Elias Malavazos et al. Obesity (Silver Spring). 2020 Jul.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Cartoon depicts imbalance between individuals with obesity and normal weight in developing COVID‐19 complications. [Color figure can be viewed at

wileyonlinelibrary.com

]

Comment in

• Increased Severity of COVID-19 in People with Obesity: Are We Overlooking Plausible Biological Mechanisms?
  Tibiriçá E, De Lorenzo A. Tibiriçá E, et al. Obesity (Silver Spring). 2020 Aug;28(8):1374. doi: 10.1002/oby.22887. Epub 2020 Jul 6. Obesity (Silver Spring). 2020. PMID: 32403201 Free PMC article. No abstract available.

Comment on

• COVID 19 and the Patient with Obesity - The Editors Speak Out.
  Ryan DH, Ravussin E, Heymsfield S. Ryan DH, et al. Obesity (Silver Spring). 2020 May;28(5):847. doi: 10.1002/oby.22808. Epub 2020 Apr 1. Obesity (Silver Spring). 2020. PMID: 32237212 Free PMC article. No abstract available.

Similar articles

• Possible Role of Adipose Tissue and the Endocannabinoid System in Coronavirus Disease 2019 Pathogenesis: Can Rimonabant Return?
  Briand-Mésange F, Trudel S, Salles J, Ausseil J, Salles JP, Chap H. Briand-Mésange F, et al. Obesity (Silver Spring). 2020 Sep;28(9):1580-1581. doi: 10.1002/oby.22916. Epub 2020 Aug 6. Obesity (Silver Spring). 2020. PMID: 32463562 Free PMC article. No abstract available.
• Epicardial Fat Inflammation in Severe COVID-19.
  Iacobellis G, Secchi F, Capitanio G, Basilico S, Schiaffino S, Boveri S, Sardanelli F, Corsi Romanelli MM, Malavazos AE. Iacobellis G, et al. Obesity (Silver Spring). 2020 Dec;28(12):2260-2262. doi: 10.1002/oby.23019. Epub 2020 Oct 15. Obesity (Silver Spring). 2020. PMID: 32862512 No abstract available.
• Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?
  Kim IC, Han S. Kim IC, et al. Eur Heart J. 2020 Jun 21;41(24):2334-2335. doi: 10.1093/eurheartj/ehaa474. Eur Heart J. 2020. PMID: 32464652 Free PMC article. No abstract available.
• Obesity, noncommunicable diseases, and COVID-19: A perfect storm.
  Katzmarzyk PT, Salbaum JM, Heymsfield SB. Katzmarzyk PT, et al. Am J Hum Biol. 2020 Sep;32(5):e23484. doi: 10.1002/ajhb.23484. Epub 2020 Aug 14. Am J Hum Biol. 2020. PMID: 32798247 Free PMC article. Review. No abstract available.
• Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?
  Ryan PM, Caplice NM. Ryan PM, et al. Obesity (Silver Spring). 2020 Jul;28(7):1191-1194. doi: 10.1002/oby.22843. Epub 2020 May 31. Obesity (Silver Spring). 2020. PMID: 32314868 Free PMC article. Review.

Cited by

• Perindopril decreases angiotensin-converting enzyme 2 (ACE2) expression in human adipocytes exposed to SARS-CoV-2 S1 spike protein.
  Harsoyo PM, Ardiana M, Hermawan HO, Purnamasari Y, Anandita FA. Harsoyo PM, et al. Narra J. 2024 Aug;4(2):e746. doi: 10.52225/narra.v4i2.746. Epub 2024 May 2. Narra J. 2024. PMID: 39280273 Free PMC article.
• Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism.
  Quagliariello V, Canale ML, Bisceglia I, Maurea C, Gabrielli D, Tarantini L, Paccone A, Inno A, Oliva S, Cadeddu Dessalvi C, Zito C, Caraglia M, Berretta M, D'Aiuto G, Maurea N. Quagliariello V, et al. Biomedicines. 2024 Jul 24;12(8):1650. doi: 10.3390/biomedicines12081650. Biomedicines. 2024. PMID: 39200115 Free PMC article. Review.
• Sociodemographic Profile and Risk Factors for the Evolution of Patients with COVID-19 in ICUs in Brazil: A Cross-Sectional Study.
  Fernandes Lira JG, Alves de Olinda R, Correia Basto da Silva G, Leal de Oliveira L, de Alencar Neta RL, Vilar Cardoso N, Adami F, da Silva Paiva L. Fernandes Lira JG, et al. ScientificWorldJournal. 2024 Jul 15;2024:2927407. doi: 10.1155/2024/2927407. eCollection 2024. ScientificWorldJournal. 2024. PMID: 39040155 Free PMC article.
• Obesity as a Risk Factor for Complications and Mortality in Individuals with SARS-CoV-2: A Systematic Review.
  de Paula Silva-Lalucci MP, Marques DCS, Valdés-Badilla P, Andreato LV, Magnani Branco BH. de Paula Silva-Lalucci MP, et al. Nutrients. 2024 Feb 16;16(4):543. doi: 10.3390/nu16040543. Nutrients. 2024. PMID: 38398867 Free PMC article.
• The impact of body mass index on long-term survival after ICU admission due to COVID-19: A retrospective multicentre study.
  Subramaniam A, Ling RR, Ridley EJ, Pilcher DV. Subramaniam A, et al. Crit Care Resusc. 2023 Nov 22;25(4):182-192. doi: 10.1016/j.ccrj.2023.10.004. eCollection 2023 Dec. Crit Care Resusc. 2023. PMID: 38234325 Free PMC article.

References

1. 1. Ryan DH, Ravussin E, Heymsfield S. COVID 19 and the patient with obesity ‐ the editors speak out. Obesity (Silver Spring) 2020;28:847. - PMC - PubMed
2. 1. ICNARC . Report on 196 patients critically ill with COVID‐19. https://www.icnarc.org/About/Latest‐News. Published March 22, 2020. Accessed March 22, 2020.
3. 1. EpiCentro ‐ Istituto Superiore di Sanità . Characteristics of COVID‐19 patients dying in Italy. Report based on available data on April 2nd, 2020. https://www.epicentro.iss.it/en/coronavirus/bollettino/Report‐COVID‐2019.... Accessed April 2, 2020.
4. 1. Li W, Moore MJ, Vasilieva N, et al. Angiotensin‐converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450‐454. - PMC - PubMed
5. 1. Gurwitz D. Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics [published online March 4, 2020]. Drug Dev Res. doi:10.1002/ddr.21656 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Archivio Istituzionale della Ricerca Unimi
  • Europe PubMed Central
  • PubMed Central
  • Wiley